Tirofiban hydrochloride
CAS No. | 142373-60-2 | Cat. No. | BCP06643 |
Name | Tirofiban hydrochloride | ||
Synonyms | Tirofiban HCl;Aggrastat; L 700462; L-700,462; MK-383; MK 383; MK383; Tirofiban; | ||
Formula | C22H37ClN2O5S | M. Wt | 477.06 |
Description | Tirofiban is an antiplatelet drug. It belongs to a class of antiplatelet named glycoprotein IIb/IIIa inhibitors. Tirofiban is the first drug candidate whose origins can be traced to a pharmacophore-based virtual screening lead. Tirofiban is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). | ||
Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
Targets | Integrin |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.